Tofacitinib: new drug approved for the treatment of patients with ulcerative colitis
Ulcerative colitis is a chronic inflammatory disease that affects the colonic mucosa. There is no curative treatment. Instead, patients must take m...
Ulcerative colitis is a chronic inflammatory disease that affects the colonic mucosa. There is no curative treatment. Instead, patients must take m...
Congenital metabolic disorders are rare diseases caused by alterations when ingested nutrients are processed. They can cause the accumulation or de...
The low blood sugar (glucose) levels experienced by people with diabetes can affect the brain. A sudden drop in glucose causes neuronal death and,...
Active smokers who have chronic obstructive pulmonary disease (COPD) are more likely to present serious forms of COVID-19. There are yet no studies...
Approximately 800,000 children and 1 million elderly people died of pneumonia around the world in 2017. Nevertheless, the severity of pneumonia is...
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced diseas...
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflamm...
Thrombosis, especially venous thrombosis, are one of the serious complications that can appear in patients affected by COVID-19. These complication...
During the COVID-19 pandemic, allergists and other specialists such as pulmonologists, ENT specialists, internists and dermatologists have attended...
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and...